As a long-term strategic partner of Oracle, NNIT is the first supplier in China that spans the entire width of implementation services of Argus (installation, verification, training, operations, and maintenance, especially CN-EN bilingual synchronous solution) which, as the most excellent global Pharmacovigilance (PV) platform, has been recognized by FDA, WHO, and relevant EU regulatory authorities, becoming the prefered choice of PV platform among global pharmaceutical giants. The platform can help ensure efficient and accurate collection, rapid analysis, and timely notification of Adverse Event data to fulfill the global regulatory requirements. NNIT has a proven track record of implementation, operation, and maintenance of Argus and has already launched a Chinese-English bilingual
Argus PV platform based on our long-term experience and continuous investment in the field of R&D,
• Monitors adverse events in the entire process from R&D, production to sales, covering such products as herbal medicines, traditional drugs, adjuvant drugs, blood products, biological products, medical devices, vaccines, and cosmetics, etc.;
The benefits you will realize when partnering with us are anchored in the optimized supporting system which will help your enterprise concentrate on the direct use of the system without unnecessary efforts being spent on its implementation and setup.
The NNIT approach to Argus has eliminated many risks associated with the validation and review of the system so that all the components of a new system can immediately be initiated while avoiding unnecessary costs and delays. As Argus implementation partner, NNIT provides not only components required for immediate initiation of the new system but also all the services and additional items. Hence, your enterprise will benefit from a ready-to-use framework that will enable transfer of massive data to usable information and facilitate the implementation of effective PV measures accordingly.